Apotex Corp. recalls Desmopressin Nasal Spray
- Recalling company
- Apotex Corp.
- Product
- Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
- Reason
- Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 8, 2026
- Reported
- Apr 22, 2026
- Distribution
- U.S.A. Nationwide
- Status
- Ongoing
- Quantity
- N/A
- Lot / codes
- Lot #: VM4231, Exp 06/30/2027
- Company location
- Weston, FL
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0510-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0510-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.